Navigation Links
Possible new blood test to diagnose heart attacks

MAYWOOD, Ill. -- Loyola University Chicago Stritch School of Medicine researchers are reporting a possible new blood test to help diagnose heart attacks.

In the Journal of Molecular and Cellular Cardiology, researchers report that a large protein known as cardiac myosin binding protein-C (cMyBP-C) is released to the blood following a heart attack.

"This potentially could become the basis for a new test, used in conjunction with other blood tests, to help diagnose heart attacks," said senior author Sakthivel Sadayappan, PhD. "This is the beginning. A lot of additional studies will be necessary to establish cMyBP-C as a true biomarker for heart attacks."

Sadayappan is an assistant professor in the Department of Cell and Molecular Physiology at Loyola University Chicago Stritch School of Medicine. First author is Suresh Govindan, PhD, a postdoctoral researcher in Sadayappan's lab.

Between 60 and 70 percent of all patients who complain of chest pain do not have heart attacks. Many of these patients are admitted to the hospital, at considerable time and expense, until a heart attack is definitively ruled out.

An electrocardiogram can diagnose major heart attacks, but not minor ones. There also are blood tests for various proteins associated with heart attacks. But most of these proteins are not specific to the heart. Elevated levels could indicate a problem other than a heart attack, such as a muscle injury.

Only one protein now used in blood tests, called cardiac troponin-I, is specific to the heart. But it takes at least four to six hours for this protein to show up in the blood following a heart attack. So the search is on for another heart attack protein that is specific to the heart.

The Loyola study is the first to find that cMyBP-C is associated with heart attacks. The protein is specific to the heart. And it may be readily detectable in a blood test because of its large molecular size and relatively high concentration in the blood.

Researchers evaluated blood samples from heart attack patients. They also evaluated rats that had experienced heart attacks. They found that in both humans and rats, cMyBP-C was elevated significantly following heart attacks.

Sadayappan said cMyBP-C is a large assembly protein that stabilizes heart muscle structure and regulates cardiac function. During a heart attack, a coronary artery is blocked, and heart muscle cells begin to die due to lack of blood flow and oxygen. As heart cells die, cMyPB-C breaks into fragments and is released into the blood.

"Future studies," Sadayappan and colleagues wrote, "would determine the time course of release, peak concentrations and half life in the circulatory system."


Contact: Jim Ritter
Loyola University Health System

Related medicine news :

1. Study suggests possible link between two Type 2 diabetes drugs and pancreatic cancer
2. Moffitt researchers find possible key to preventing chemotherapy resistance in ovarian cancer
3. University of Maryland researchers discover possible drug targets for common non-Hodgkins lymphoma
4. Scientists Spot Possible Target in Ovarian Cancer
5. New research points to a possible gender link in knee injuries
6. Sequence of ovarian genome identifies predominant gene mutations, points to possible treatment
7. Study reveals possible brain damage in young adult binge-drinkers
8. Poor Brain Sync a Possible Sign of Autism
9. Possible susceptibility genes found in neurodegenerative disorder
10. Chemical Found in Foam Cups a Possible Carcinogen
11. Earpieces Can Minimize Possible Risks From Cellphones, Experts Say
Post Your Comments:
Related Image:
Possible new blood test to diagnose heart attacks
(Date:11/30/2015)... ... November 30, 2015 , ... Brenntag Specialties, Inc. (BSI) has ... the Nutraceutical Specialties products into oral solid dosage in the over the counter ... are pleased to announce our expanded distribution agreement with ASI.” said Steve Brauer, ...
(Date:11/30/2015)... ... November 30, 2015 , ... California-based i2i Systems, ... announced today that Michigan-based Family Health Center (FHC) has selected i2iTracks as their ... FHC was awarded the largest Affordable Care Act grant for Federally Qualified Health ...
(Date:11/30/2015)... ... November 30, 2015 , ... An inventor from Charlottesville, Va., is ... "My last baby had high blood pressure due to loud noises," she said, "so ... babies from noise pollution as well as radio waves and microwaves." , The baby ...
(Date:11/30/2015)... ... November 30, 2015 , ... In an interview with Andy Mitchell of Peconic ... on Long Island’s east end. During the broadcast, entitled “Eyes: the Window to the ... glaucoma and cataracts, and how a visit with his grandmother to her physician put ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... magazines and websites specializing in independent living, assisted living and all other retirement ... Alzheimer’s awareness and research remains a top priority. , So ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 2015  Hanger, Inc. (NYSE: HGR ) (the ... terms of its previously announced consent solicitation (as amended ... aggregate principal amount 7⅛% Senior Notes due 2018 (the ... fees payable pursuant to the Consent Solicitation, (ii) the ... the expiration date of the Consent Solicitation.    ...
(Date:11/30/2015)... , Nov. 30, 2015  Precision Image Analysis ... is pleased to announce a dramatic expansion of ... services. Building on its ISO-9001:2008 certification for its ... comprehensive Core Lab protocols and procedures. This expansion ... research activities.  Their Core Lab services include design ...
(Date:11/30/2015)... and REHOVOT, Israel , ... specialty pharmaceutical company focused on acquiring and developing innovative ... announced the appointment of Keith A. Katkin ... Gregory J. Flesher , chief executive officer for ... building successful organizations.  As chairman, he will be able ...
Breaking Medicine Technology: